Keep away from concomitant usage of tucatinib with CYP3A substrates, exactly where small concentration modifications may possibly produce serious or lifetime-threatening toxicities. If unavoidable, reduce CYP3A substrate dose according to merchandise labeling.Watch Carefully (1)modafinil will improve the level or effect of flibanserin by affecting